Plain-English translation of NCT06644144 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that tracks people with various types of lung fibrosis or early lung abnormalities over five years. Researchers will collect medical information and biological samples (like blood) during regular clinic visits to understand which patients are likely to get worse and to develop more personalized treatment approaches.
Lung fibrosis can progress at very different speeds from person to person, and doctors currently have difficulty predicting who will deteriorate quickly. This study aims to find better ways to identify patients at higher risk early on, so they can receive more tailored care and monitoring.
You likely qualify if…
You likely don't qualify if…
You would visit Amsterdam UMC at baseline and then at 3, 6, 12, 24, 36, 48, and 60 months — so study visits spread over five years. During each visit, you'll have lung function tests, possibly a CT scan, and blood or tissue samples taken. These visits align with your regular clinical follow-up appointments, so the study fits into your normal care routine.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
Netherlands